Sleep Apnea Syndromes Clinical Trial
Official title:
Respiratory and Autonomic Plasticity Following Intermittent Hypoxia
The prevalence of obstructive sleep apnea is high in the Veteran population. If not treated promptly, sleep apnea may result in daytime fatigue which may lead to increased prevalence of accidents while driving or in the workplace. Recent large scale epidemiological studies have shown that the prevalence of excessive daytime sleepiness increases in individuals who suffer from obstructive sleep apnea. Obstructive sleep apnea may also result in the development of hypertension and other cardiovascular disorders. Previous findings have shown that subjects with sleep apnea have a greater risk for developing coronary vascular disease compared to individuals that do not suffer from sleep apnea Thus, a significant amount of evidence suggests that sleep apnea is a major health concern in the Veteran population. Consequently, determining the mechanisms that may impact on the severity of sleep apnea and increase the prevalence of cardiovascular incidents associated with this disorder is important, as is discovering novel treatments.
Approximately 8 % of the Veteran population in the United States suffers from sleep apnea. Consequences of untreated sleep apnea include increased daytime fatigue, hypertension and stroke. Thus, sleep apnea is a major health concern. One of the primary hallmarks of sleep apnea is exposure to intermittent hypoxia (IH) which occurs as a consequence of central or obstructive apneas. Exposure to IH may lead to neural plasticity (i.e. a change in system performance based on prior experience) of the respiratory and autonomic nervous system. One adaptation that has been shown to manifest itself in animals following exposure to IH is long-term facilitation (LTF) of ventilation and sympathetic nervous system activity (SNSA). This phenomenon is characterized by a gradual increase in respiratory motor activity and SNSA during successive periods of normoxia that separate hypoxic episodes and by activity that persists above baseline levels for up to 90 minutes following exposure to IH. Although LTF of minute ventilation has been well established in animals it has not been observed consistently in healthy humans or in individuals with obstructive sleep apnea. Similarly, although a few studies have shown that exposure to IH leads to increases in SNSA in healthy individuals the magnitude of the response has varied significantly. Findings from animal studies suggest that the manifestation of LTF in humans might in part be dependent on a variety of factors, including prior exposure to IH, arousal state (wake vs. sleep) and gender. Thus, the initial aim of our proposal will establish whether LTF can be induced in healthy humans and individuals with obstructive sleep apnea and whether the magnitude of the response is dependent on those factors mentioned above. Moreover, the initial aim will explore whether the presence of LTF of minute ventilation promotes or mitigates apnea severity. Animal studies have also indicated that LTF of respiratory and autonomic activity may in part be induced by increases in oxidative stress. Thus, the second objective of our proposal will explore whether administration of an antioxidant cocktail impacts respiratory and autonomic nervous system plasticity during wakefulness and sleep following IH. Likewise, the second aim will explore whether administration of an antioxidant cocktail alters apnea severity following exposure to IH. Establishing whether LTF of minute ventilation exists in individuals with sleep apnea is important since activation of this phenomenon could impact on apnea severity across the night. Similarly, LTF of SNSA activity and possibly long-term depression (LTD) of parasympathetic nervous system activity (PNSA) could ultimately lead to persistent increases in blood pressure and heart rate. Furthermore, given that exposure to IH may lead to long-term plasticity of respiratory and autonomic activity that are physiologically detrimental, exploring mechanisms that ultimately lead to treatments that may mitigate or prevent the manifestation of this phenomenon are important. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05477719 -
Effect of Compression Stockings on the Number of Apneas/Hypopneas Per Hour of Sleep in Patients With Syndrome Obstructive Sleep Apnea/Hypopnea as Compared to no Treatment
|
N/A | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A | |
Terminated |
NCT02735694 -
Cycloserine in the Treatment of Sleep Apnea
|
Phase 1 | |
Active, not recruiting |
NCT02470182 -
Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
|
||
Completed |
NCT02088723 -
Testing the Elevation as Sleep Apnea Treatment
|
N/A | |
Completed |
NCT01457014 -
Sleep Disordered Breathing and Chronic Pain
|
N/A | |
Completed |
NCT00976417 -
Mechanisms of Action of Adaptive Servoventilation
|
N/A | |
Active, not recruiting |
NCT00371293 -
The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00070681 -
Outcomes of Sleep Disorders in Older Men
|
Phase 3 | |
Completed |
NCT00051363 -
Apnea Positive Pressure Long-Term Efficacy Study
|
Phase 3 | |
Completed |
NCT00046670 -
Sleep Disordered Breathing, APOE, and Lipid Metabolism
|
N/A | |
Completed |
NCT00031239 -
Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD
|
N/A | |
Completed |
NCT00006323 -
Neurobehavioral Consequences of Sleep Apnea in Children
|
N/A | |
Terminated |
NCT00006321 -
Neurocognitive Function in Snoring Children
|
N/A | |
Completed |
NCT00005511 -
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
|
N/A | |
Completed |
NCT00005275 -
Sleep Heart Health Study (SHHS) Data Coordinating Center
|
N/A | |
Completed |
NCT00005321 -
Epidemiology of Sleep Disordered Breathing - SCOR in Cardiopulmonary Disorders of Sleep
|
N/A |